ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 134 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2019. The put-call ratio across all filers is 3.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $19,610,000 | -28.5% | 698,859 | -13.4% | 0.41% | -21.3% |
| Q3 2021 | $27,422,000 | -34.8% | 806,769 | -21.6% | 0.52% | -30.3% |
| Q2 2021 | $42,049,000 | +1.9% | 1,029,114 | +0.4% | 0.75% | -4.7% |
| Q1 2021 | $41,250,000 | -30.0% | 1,024,583 | +2.7% | 0.78% | -24.1% |
| Q4 2020 | $58,967,000 | +22.2% | 997,249 | +0.5% | 1.03% | +6.5% |
| Q3 2020 | $48,272,000 | +28.3% | 992,639 | +27.7% | 0.97% | +8.0% |
| Q2 2020 | $37,620,000 | +105.6% | 777,590 | +18.1% | 0.90% | +30.2% |
| Q1 2020 | $18,298,000 | +89.5% | 658,650 | +104.1% | 0.69% | +92.5% |
| Q4 2019 | $9,654,000 | – | 322,660 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |